Literature DB >> 33669221

Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer.

Sugandha Saxena1, Dipakkumar R Prajapati1, Paran Goel1, Babita Tomar1, Yuri Hayashi1, Pranita Atri2, Satyanarayana Rachagani2, Paul M Grandgenett3, Michael A Hollingsworth3, Surinder K Batra2, Rakesh K Singh1.   

Abstract

The Plexins family of proteins are well-characterized transmembrane receptors of semaphorins, axon guidance cue molecules, that mediate the cell attraction or repelling effects for such cues. Plexins and their ligands are involved in numerous cellular activities, such as motility, invasion, and adhesion to the basement membrane. The detachment of cells and the gain in motility and invasion are hallmarks of the cancer metastasis cascade, thus generating interest in exploring the role of plexins in cancer metastasis. Semaphorin-plexin complexes can act as tumor promoters or suppressors, depending upon the cancer type, and are under investigation for therapeutic purposes. Our group has identified Semaphorin-5A (SEMA5A)/Plexin-B3 as an attractive targetable complex for pancreatic cancer (PC) metastasis. However, our understanding of the Plexin-B3 function and pathological expression in PC is limited, and our present study delineates the role of Plexin-B3 in PC malignancy. We examined the pathological expression of Plexin-B3 in PC tumors and metastasis using a human tissue microarray, disease progression model of PDX-Cre-Kras(G12D) (KC) mice, and different metastatic sites obtained from the KrasG12D; Trp53R172H; Pdx1-Cre (KPC) mice model. We observed a higher Plexin-B3 expression in PC tumor cores than the normal pancreas, and different metastatic sites were positive for Plexin-B3 expression. However, in the KC mice model, the Plexin-B3 expression increased initially and then decreased with the disease progression. Next, to evaluate the functional role of Plexin-B3, we utilized T3M-4- and CD18/HPAF-Control and -Plexin B3 knockdown cells for different in vivo and in vitro studies. The knockdown of Plexin-B3 enhanced the in vitro cellular migration, invasiveness, and impaired colony formation in three-dimensional culture, along with an increase in cellular spread and remodeling of the actin filaments. We also observed a higher metastasis in nude mice injected with T3M-4- and CD18/HPAF-shPlexin-B3 cells compared to their respective control cells. Furthermore, we observed a lower number of proliferating Ki-67-positive cells and higher ALDH1-A1-positive cells in the tumors formed by Plexin-B3 knockdown cells compared to tumors formed by the control cells. Together, our data suggest that the loss of Plexin-B3 is associated with the interference of cell division machinery and the induction of stem cell-like characteristics in PC cells.

Entities:  

Keywords:  Plexin-B3; cancer stem cells; cellular motility; metastasis; pancreatic cancer

Year:  2021        PMID: 33669221      PMCID: PMC7919786          DOI: 10.3390/cancers13040818

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.575


  47 in total

1.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

Review 2.  Pancreatic cancer metastasis: are we being pre-EMTed?

Authors:  Srustidhar Das; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.

Authors:  Bhawna Sharma; Michelle L Varney; Sugandha Saxena; Lingyun Wu; Rakesh K Singh
Journal:  Cancer Lett       Date:  2016-01-12       Impact factor: 8.679

4.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

Authors:  Andrew V Biankin; Nicola Waddell; Karin S Kassahn; Marie-Claude Gingras; Lakshmi B Muthuswamy; Amber L Johns; David K Miller; Peter J Wilson; Ann-Marie Patch; Jianmin Wu; David K Chang; Mark J Cowley; Brooke B Gardiner; Sarah Song; Ivon Harliwong; Senel Idrisoglu; Craig Nourse; Ehsan Nourbakhsh; Suzanne Manning; Shivangi Wani; Milena Gongora; Marina Pajic; Christopher J Scarlett; Anthony J Gill; Andreia V Pinho; Ilse Rooman; Matthew Anderson; Oliver Holmes; Conrad Leonard; Darrin Taylor; Scott Wood; Qinying Xu; Katia Nones; J Lynn Fink; Angelika Christ; Tim Bruxner; Nicole Cloonan; Gabriel Kolle; Felicity Newell; Mark Pinese; R Scott Mead; Jeremy L Humphris; Warren Kaplan; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Angela Chou; Venessa T Chin; Lorraine A Chantrill; Amanda Mawson; Jaswinder S Samra; James G Kench; Jessica A Lovell; Roger J Daly; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nipun Kakkar; Fengmei Zhao; Yuan Qing Wu; Min Wang; Donna M Muzny; William E Fisher; F Charles Brunicardi; Sally E Hodges; Jeffrey G Reid; Jennifer Drummond; Kyle Chang; Yi Han; Lora R Lewis; Huyen Dinh; Christian J Buhay; Timothy Beck; Lee Timms; Michelle Sam; Kimberly Begley; Andrew Brown; Deepa Pai; Ami Panchal; Nicholas Buchner; Richard De Borja; Robert E Denroche; Christina K Yung; Stefano Serra; Nicole Onetto; Debabrata Mukhopadhyay; Ming-Sound Tsao; Patricia A Shaw; Gloria M Petersen; Steven Gallinger; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Richard D Schulick; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Paola Capelli; Vincenzo Corbo; Maria Scardoni; Giampaolo Tortora; Margaret A Tempero; Karen M Mann; Nancy A Jenkins; Pedro A Perez-Mancera; David J Adams; David A Largaespada; Lodewyk F A Wessels; Alistair G Rust; Lincoln D Stein; David A Tuveson; Neal G Copeland; Elizabeth A Musgrove; Aldo Scarpa; James R Eshleman; Thomas J Hudson; Robert L Sutherland; David A Wheeler; John V Pearson; John D McPherson; Richard A Gibbs; Sean M Grimmond
Journal:  Nature       Date:  2012-10-24       Impact factor: 49.962

5.  Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis.

Authors:  Anguraj Sadanandam; Michelle L Varney; Leo Kinarsky; Hesham Ali; R Lee Mosley; Rakesh K Singh
Journal:  OMICS       Date:  2007

Review 6.  EMT, the cytoskeleton, and cancer cell invasion.

Authors:  Mahmut Yilmaz; Gerhard Christofori
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

7.  Expression of semaphorin 5A and its receptor plexin B3 contributes to invasion and metastasis of gastric carcinoma.

Authors:  Guo-Qing Pan; Hong-Zheng Ren; Shu-Fang Zhang; Xi-Mei Wang; Ji-Fang Wen
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

8.  Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.

Authors:  Kana Tominaga; Hiroshi Minato; Takahiko Murayama; Asako Sasahara; Tatsunori Nishimura; Etsuko Kiyokawa; Hajime Kanauchi; Seiichiro Shimizu; Ayaka Sato; Kotoe Nishioka; Ei-Ichi Tsuji; Masao Yano; Toshihisa Ogawa; Hideshi Ishii; Masaki Mori; Koichi Akashi; Koji Okamoto; Masahiko Tanabe; Kei-Ichiro Tada; Arinobu Tojo; Noriko Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-26       Impact factor: 11.205

Review 9.  Semaphorins in cancer: biological mechanisms and therapeutic approaches.

Authors:  Michael Rehman; Luca Tamagnone
Journal:  Semin Cell Dev Biol       Date:  2012-10-23       Impact factor: 7.727

Review 10.  Semaphorin 3C and Its Receptors in Cancer and Cancer Stem-Like Cells.

Authors:  Jing Hao; Jennifer S Yu
Journal:  Biomedicines       Date:  2018-04-08
View more
  1 in total

1.  Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.

Authors:  Laura Kuhlmann; Meinusha Govindarajan; Salvador Mejia-Guerrero; Vladimir Ignatchenko; Lydia Y Liu; Barbara T Grünwald; Jennifer Cruickshank; Hal Berman; Rama Khokha; Thomas Kislinger
Journal:  J Proteome Res       Date:  2022-08-18       Impact factor: 5.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.